| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 661397 | 62015 | TIONER 100 MG/ML SOLUCION ORAL | TIONER 100 MG/ML SOLUCION ORAL , 1 frasco de 30 ml | 100 mg/ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62015/62015_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62015/62015_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13469 | ARISTO PHARMA IBERIA S.L. | 1998-12-01 | 1 | 1 | 1 | 1998-12-01 | 1998-12-01 | 1 | 2011-10-10 | View Edit Delete | ||||||||||||
| 660936 | 62044 | AGUA PARA PREPARACIONES INYECTABLES BEXEN DISOLVENTE PARA USO PARENTERAL | AGUA PARA PREPARACIONES INYECTABLES BEXEN DISOLVENTE PARA USO PARENTERAL , 1 ampolla de 5 ml | N/A (agua estéril) | 6 | 1 | 1 | 1 ampolla de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62044/62044_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62044/62044_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3978 | OIARSO SOCIEDAD COOPERATIVA | 1998-10-01 | 1 | 1 | 1 | 1998-10-01 | 1998-10-01 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 661163 | 69909 | EPTADONE 100 mg SOLUCION ORAL | EPTADONE 100 mg SOLUCION ORAL, 1 frasco unidosis de 20 ml | 100 mg | 6 | 1 | 17 | 1 frasco unidosis de 20 ml | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69909/69909_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69909/69909_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1585 | LABORATORIOS GEBRO PHARMA S.A. | 2008-06-24 | 1 | 1 | 1 | 2008-06-24 | 2008-06-24 | 1 | 2011-10-10 | Lista I | View Edit Delete | |||||||||||
| 661167 | 69913 | EPTADONE 20 mg SOLUCION ORAL | EPTADONE 20 mg SOLUCION ORAL, 1 frasco unidosis de 20 ml | 20 mg | 6 | 1 | 17 | 1 frasco unidosis de 20 ml | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69913/69913_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69913/69913_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1585 | LABORATORIOS GEBRO PHARMA S.A. | 2008-06-24 | 1 | 1 | 1 | 2008-06-24 | 2008-06-24 | 1 | 2011-10-10 | Lista I | View Edit Delete | |||||||||||
| 661524 | 07413001 | GLIOLAN 30 MG/ML POLVO PARA SOLUCION ORAL | GLIOLAN 30 MG/ML POLVO PARA SOLUCION ORAL, 1 frasco | 1.500 mg | 6 | 50 | 26 | 1 frasco | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07413001/07413001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07413001/07413001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 40575 | LABORATORIOS GEBRO PHARMA S.A. | 2009-11-12 | 1 | 1 | 1 | 2009-11-12 | 2009-11-12 | 0 | 2011-02-15 | View Edit Delete | ||||||||||||
| 661466 | 52373 | AMOXICILINA ARDINE 125 mg/5 ml POLVO PARA SUSPENSION ORAL EFG | AMOXICILINA ARDINE 125 mg/5 ml POLVO PARA SUSPENSION ORAL EFG, 1 frasco de 120 ml | 125 mg/5 ml | 6 | 120 | 26 | 1 frasco de 120 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/52373/52373_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/52373/52373_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2367 | LABORATORIO REIG JOFRE, S.A. | 1974-05-01 | 1 | 1 | 1 | 1974-05-01 | 2008-09-26 | 1 | 2011-02-08 | 711028 | View Edit Delete | |||||||||||
| 661467 | 53626 | AMOXICILINA ARDINE 250 mg/5 ml POLVO PARA SUSPENSION ORAL EFG | AMOXICILINA ARDINE 250 mg/5 ml POLVO PARA SUSPENSION ORAL EFG , 1 frasco de 120 ml | 250 mg/5 ml | 6 | 120 | 26 | 1 frasco de 120 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/53626/53626_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/53626/53626_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2367 | LABORATORIO REIG JOFRE, S.A. | 1976-02-01 | 1 | 1 | 1 | 1976-02-01 | 2008-09-26 | 1 | 2011-02-08 | 939314 | View Edit Delete | |||||||||||
| 660331 | 69514 | RISPERIDONA TEVA 1 mg/ml SOLUCION ORAL EFG | RISPERIDONA TEVA 1 mg/ml SOLUCION ORAL EFG, 1 frasco de 100 ml | 1 mg/ml | 6 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69514/69514_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69514/69514_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2007-12-28 | 1 | 1 | 1 | 2007-12-28 | 2007-12-28 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 660653 | 69669 | CABERGOLINA TEVA 0,5 mg COMPRIMIDOS EFG | CABERGOLINA TEVA 0,5 mg COMPRIMIDOS EFG , 2 comprimidos | 0,5 mg | 6 | 2 | 10 | 2 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69669/69669_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69669/69669_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2008-03-18 | 1 | 1 | 1 | 2008-03-18 | 2008-03-18 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 660655 | 69669 | CABERGOLINA TEVA 0,5 mg COMPRIMIDOS EFG | CABERGOLINA TEVA 0,5 mg COMPRIMIDOS EFG , 8 comprimidos | 0,5 mg | 6 | 8 | 10 | 8 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69669/69669_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69669/69669_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2008-03-18 | 1 | 1 | 1 | 2008-03-18 | 2008-03-18 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 660713 | 69686 | CABERGOLINA TEVA 2 mg COMPRIMIDOS EFG | CABERGOLINA TEVA 2 mg COMPRIMIDOS EFG , 20 comprimidos | 2 mg | 6 | 20 | 10 | 20 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69686/69686_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69686/69686_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2008-03-18 | 1 | 1 | 1 | 2008-03-18 | 2008-03-18 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 660714 | 69687 | CABERGOLINA TEVA 1 mg COMPRIMIDOS EFG | CABERGOLINA TEVA 1 mg COMPRIMIDOS EFG , 20 comprimidos | 1 mg | 6 | 20 | 10 | 20 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69687/69687_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69687/69687_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2008-03-18 | 1 | 1 | 1 | 2008-03-18 | 2008-03-18 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 661621 | 69516 | AZITROMICINA TEVA 200 mg/5ml POLVO PARA SUSPENSIÓN ORAL EFG | AZITROMICINA TEVA 200 mg/5ml POLVO PARA SUSPENSIÓN ORAL EFG , 1 frasco de 30 ml | 200 mg/5 ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69516/69516_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69516/69516_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2008-01-10 | 1 | 1 | 1 | 2008-01-10 | 2008-01-10 | 1 | 2011-10-24 | 660337 | View Edit Delete | |||||||||||
| 660684 | 69670 | OSVAREN 435 mg / 235 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | OSVAREN 435 mg / 235 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 180 comprimidos | 435 mg/235 mg | 6 | 180 | 10 | 180 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69670/69670_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69670/69670_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28033 | VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA ESPAÑA S.L. | 2008-03-10 | 1 | 1 | 1 | 2008-03-10 | 2008-03-10 | 1 | 2011-10-10 | View Edit Delete | ||||||||||||
| 661639 | 06367002 | DIACOMIT 250 mg CAPSULAS DURAS | DIACOMIT 250 mg CAPSULAS DURAS, 60 cápsulas | 250 mg | 6 | 60 | 43 | 60 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06367002/06367002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06367002/06367002_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 68155 | BIOCODEX | 2009-11-12 | 1 | 1 | 1 | 2009-11-12 | 2009-11-12 | 1 | 2015-11-11 | View Edit Delete | ||||||||||||
| 661641 | 06367005 | DIACOMIT 500 mg CAPSULAS DURAS | DIACOMIT 500 mg CAPSULAS DURAS, 60 cápsulas | 500 mg | 6 | 60 | 43 | 60 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06367005/06367005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06367005/06367005_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 68155 | BIOCODEX | 2009-11-12 | 1 | 1 | 1 | 2009-11-12 | 2009-11-12 | 1 | 2019-10-28 | View Edit Delete | ||||||||||||
| 661057 | 03260021 | STALEVO 200 mg/50 mg/200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | STALEVO 200 mg/50 mg/200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 100 comprimidos | 200 mg/50 mg/200 mg | 6 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/03260021/03260021_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/03260021/03260021_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42344 | ORION PHARMA S.L. | 2008-06-10 | 1 | 1 | 1 | 2008-06-10 | 2008-06-10 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 660432 | 69553 | RISPERIDONA VIATRIS 1 MG/ML SOLUCION ORAL EFG | RISPERIDONA VIATRIS 1 MG/ML SOLUCION ORAL EFG, 1 frasco de 100 ml | 1 mg/ml | 6 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69553/69553_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69553/69553_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | VIATRIS PHARMACEUTICALS S.L.U. | 2008-01-28 | 1 | 1 | 1 | 2008-01-28 | 2008-01-28 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 660782 | 69726 | DALSY 40 mg/ml SUSPENSION ORAL | DALSY 40 mg/ml SUSPENSION ORAL , 1 frasco de 150 ml | 40 mg/ml | 6 | 150 | 26 | 1 frasco de 150 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69726/69726_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69726/69726_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | VIATRIS PHARMACEUTICALS S.L. | 2008-04-07 | 1 | 1 | 1 | 2008-04-07 | 2008-04-07 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 660752 | 01172006 | KALETRA 100 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | KALETRA 100 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 60 comprimidos | 100 mg/25 mg | 6 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/01172006/01172006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/01172006/01172006_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 41086 | ABBVIE SPAIN, S.L.U. | 2008-04-24 | 1 | 1 | 1 | 2008-04-24 | 2008-04-24 | 1 | 2012-01-09 | View Edit Delete |
Page 171 of 1035, showing 20 records out of 20697 total, starting on record 3401, ending on 3420